Skip to main content
Top
Published in: Acta Diabetologica 1/2010

01-12-2010 | Original Article

Hyperglycaemia in critical illness is a risk factor for later development of type II diabetes mellitus

Authors: Ivan Gornik, Ana Vujaklija, Edita Lukić, Goran Madžarac, Vladimir Gašparović

Published in: Acta Diabetologica | Special Issue 1/2010

Login to get access

Abstract

Hyperglycaemia caused by stress and inflammation is common during critical illness. We hypothesised that a latent glucose metabolism disturbance contributes to development of hyperglycaemia and that those patients have increased risk for diabetes. We included patients with sepsis, acute coronary syndrome and acute heart failure with no history of impaired glucose metabolism and divided them in the hyperglycaemia group (glucose ≥ 7.8 mmol/l) and normoglycaemia group. Patients were followed for 5 years. Follow-up was completed for 115 patients in the normoglycaemia group, of which 4 (3.5%) developed type 2 diabetes. In the hyperglycaemia group 51 patients finished follow-up and 8 (15.7%) developed type 2 diabetes. Relative risk in 5-year period for patients with hyperglycaemia was 4.51 for development of type 2 diabetes. Patients with hyperglycaemia during critical illness who are not diagnosed with diabetes before or during the hospitalisation should be considered a population at increased risk for developing diabetes.
Literature
1.
go back to reference Benfield T, Jensen JS, Nordestgaard BG (2007) Influence of diabetes and hyperglycaemia on infectious disease hospitalisation and outcome. Diabetologia 50:549–554CrossRefPubMed Benfield T, Jensen JS, Nordestgaard BG (2007) Influence of diabetes and hyperglycaemia on infectious disease hospitalisation and outcome. Diabetologia 50:549–554CrossRefPubMed
2.
go back to reference Christiansen C, Toft P, Jorgensen HS et al (2004) Hyperglycaemia and mortality in critically ill patients. A prospective study. Intensive Care Med 30:1685–1688CrossRefPubMed Christiansen C, Toft P, Jorgensen HS et al (2004) Hyperglycaemia and mortality in critically ill patients. A prospective study. Intensive Care Med 30:1685–1688CrossRefPubMed
3.
go back to reference van den Berghe G, Wouters P, Weekers F et al (2001) Intensive insulin therapy in the critically ill patients. N Engl J Med 345:1359–1367CrossRefPubMed van den Berghe G, Wouters P, Weekers F et al (2001) Intensive insulin therapy in the critically ill patients. N Engl J Med 345:1359–1367CrossRefPubMed
4.
go back to reference Malmberg K, Norhammar A, Wedel H et al (1999) Glycometabolic state at admission: important risk marker of mortality in conventionally treated patients with diabetes mellitus and acute myocardial infarction: long-term results from the Diabetes and Insulin-Glucose Infusion in Acute Myocardial Infarction (DIGAMI) study. Circulation 99:2626–2632PubMed Malmberg K, Norhammar A, Wedel H et al (1999) Glycometabolic state at admission: important risk marker of mortality in conventionally treated patients with diabetes mellitus and acute myocardial infarction: long-term results from the Diabetes and Insulin-Glucose Infusion in Acute Myocardial Infarction (DIGAMI) study. Circulation 99:2626–2632PubMed
5.
go back to reference Van den Berghe G (2002) Neuroendocrine pathobiology of chronic critical illness. Crit Care Clin 18:509–528CrossRefPubMed Van den Berghe G (2002) Neuroendocrine pathobiology of chronic critical illness. Crit Care Clin 18:509–528CrossRefPubMed
6.
go back to reference Langouche L, Van den Berghe G (2006) The dynamic neuroendocrine response to critical illness. Endocrinol Metab Clin North Am 35:777–791, ix Langouche L, Van den Berghe G (2006) The dynamic neuroendocrine response to critical illness. Endocrinol Metab Clin North Am 35:777–791, ix
7.
go back to reference McCowen KC, Malhotra A, Bistrian BR (2001) Stress-induced hyperglycemia. Crit Care Clin 17:107–124CrossRefPubMed McCowen KC, Malhotra A, Bistrian BR (2001) Stress-induced hyperglycemia. Crit Care Clin 17:107–124CrossRefPubMed
8.
go back to reference Grimble RF (2002) Inflammatory status and insulin resistance. Curr Opin Clin Nutr Metab Care 5:551–559CrossRefPubMed Grimble RF (2002) Inflammatory status and insulin resistance. Curr Opin Clin Nutr Metab Care 5:551–559CrossRefPubMed
9.
go back to reference Marette A (2002) Mediators of cytokine-induced insulin resistance in obesity and other inflammatory settings. Curr Opin Clin Nutr Metab Care 5:377–383CrossRefPubMed Marette A (2002) Mediators of cytokine-induced insulin resistance in obesity and other inflammatory settings. Curr Opin Clin Nutr Metab Care 5:377–383CrossRefPubMed
10.
go back to reference Marik PE, Raghavan M (2004) Stress-hyperglycemia, insulin and immunomodulation in sepsis. Intensive Care Med 30:748–756CrossRefPubMed Marik PE, Raghavan M (2004) Stress-hyperglycemia, insulin and immunomodulation in sepsis. Intensive Care Med 30:748–756CrossRefPubMed
11.
go back to reference Aljada A, Ghanim H, Assian E et al (2002) Tumor necrosis factor-alpha inhibits insulin-induced increase in endothelial nitric oxide synthase and reduces insulin receptor content and phosphorylation in human aortic endothelial cells. Metabolism 51:487–491CrossRefPubMed Aljada A, Ghanim H, Assian E et al (2002) Tumor necrosis factor-alpha inhibits insulin-induced increase in endothelial nitric oxide synthase and reduces insulin receptor content and phosphorylation in human aortic endothelial cells. Metabolism 51:487–491CrossRefPubMed
12.
go back to reference Mizock BA (2001) Alterations in fuel metabolism in critical illness: hyperglycaemia. Best Pract Res Clin Endocrinol Metab 15:533–551CrossRefPubMed Mizock BA (2001) Alterations in fuel metabolism in critical illness: hyperglycaemia. Best Pract Res Clin Endocrinol Metab 15:533–551CrossRefPubMed
13.
go back to reference Clowes GH Jr, Martin H, Walji S et al (1978) Blood insulin responses to blood glucose levels in high output sepsis and septic shock. Am J Surg 135:577–583CrossRefPubMed Clowes GH Jr, Martin H, Walji S et al (1978) Blood insulin responses to blood glucose levels in high output sepsis and septic shock. Am J Surg 135:577–583CrossRefPubMed
14.
go back to reference Dahn MS, Jacobs LA, Smith S et al (1985) The relationship of insulin production to glucose metabolism in severe sepsis. Arch Surg 120:166–172PubMed Dahn MS, Jacobs LA, Smith S et al (1985) The relationship of insulin production to glucose metabolism in severe sepsis. Arch Surg 120:166–172PubMed
15.
go back to reference Mehta VK, Hao W, Brooks-Worrell BM et al (1994) Low-dose interleukin 1 and tumor necrosis factor individually stimulate insulin release but in combination cause suppression. Eur J Endocrinol 130:208–214CrossRefPubMed Mehta VK, Hao W, Brooks-Worrell BM et al (1994) Low-dose interleukin 1 and tumor necrosis factor individually stimulate insulin release but in combination cause suppression. Eur J Endocrinol 130:208–214CrossRefPubMed
16.
go back to reference Metso AJ, Murros K (2007) Hyperglycaemia and the outcome of stroke. Brain 130:e85 (author reply e86)CrossRefPubMed Metso AJ, Murros K (2007) Hyperglycaemia and the outcome of stroke. Brain 130:e85 (author reply e86)CrossRefPubMed
17.
go back to reference Cubbon RM, Rajwani A, Abbas A et al (2007) Hyperglycaemia, in relation to sex, and mortality after acute coronary syndrome. Eur J Cardiovasc Prev Rehabil 14:666–671CrossRefPubMed Cubbon RM, Rajwani A, Abbas A et al (2007) Hyperglycaemia, in relation to sex, and mortality after acute coronary syndrome. Eur J Cardiovasc Prev Rehabil 14:666–671CrossRefPubMed
18.
go back to reference American Diabetes Association (2008) Diagnosis and classification of diabetes mellitus. Diabetes Care 31(Suppl 1):S55–S60 American Diabetes Association (2008) Diagnosis and classification of diabetes mellitus. Diabetes Care 31(Suppl 1):S55–S60
19.
go back to reference Levy MM, Fink MP, Marshall JC et al (2003) 2001 SCCM/ESICM/ACCP/ATS/SIS international sepsis definitions conference. Intensive Care Med 29:530–538PubMed Levy MM, Fink MP, Marshall JC et al (2003) 2001 SCCM/ESICM/ACCP/ATS/SIS international sepsis definitions conference. Intensive Care Med 29:530–538PubMed
20.
go back to reference Pollack CV Jr, Braunwald E (2008) 2007 update to the ACC/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction: implications for emergency department practice. Ann Emerg Med 51:591–606CrossRefPubMed Pollack CV Jr, Braunwald E (2008) 2007 update to the ACC/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction: implications for emergency department practice. Ann Emerg Med 51:591–606CrossRefPubMed
21.
go back to reference Braunwald E, Antman EM, Beasley JW et al (2000) ACC/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Unstable Angina). J Am Coll Cardiol 36:970–1062CrossRefPubMed Braunwald E, Antman EM, Beasley JW et al (2000) ACC/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Unstable Angina). J Am Coll Cardiol 36:970–1062CrossRefPubMed
22.
go back to reference Goran KP (2007) The consensus is clearly needed for the definition of stress hyperglycaemia in acute myocardial infarction. Eur Heart J 28:2042 (author reply 2042–2043)CrossRefPubMed Goran KP (2007) The consensus is clearly needed for the definition of stress hyperglycaemia in acute myocardial infarction. Eur Heart J 28:2042 (author reply 2042–2043)CrossRefPubMed
23.
go back to reference Deedwania P, Kosiborod M, Barrett E et al (2008) Hyperglycemia and acute coronary syndrome: a scientific statement from the American Heart Association Diabetes Committee of the Council on Nutrition, Physical Activity, and Metabolism. Circulation 117:1610–1619CrossRefPubMed Deedwania P, Kosiborod M, Barrett E et al (2008) Hyperglycemia and acute coronary syndrome: a scientific statement from the American Heart Association Diabetes Committee of the Council on Nutrition, Physical Activity, and Metabolism. Circulation 117:1610–1619CrossRefPubMed
24.
go back to reference Inzucchi SE, Rosenstock J (2005) Counterpoint: inpatient glucose management: a premature call to arms? Diabetes Care 28:976–979CrossRefPubMed Inzucchi SE, Rosenstock J (2005) Counterpoint: inpatient glucose management: a premature call to arms? Diabetes Care 28:976–979CrossRefPubMed
25.
go back to reference Bryer-Ash M, Garber AJ (2005) Point: inpatient glucose management: the emperor finally has clothes. Diabetes Care 28:973–975CrossRefPubMed Bryer-Ash M, Garber AJ (2005) Point: inpatient glucose management: the emperor finally has clothes. Diabetes Care 28:973–975CrossRefPubMed
26.
go back to reference Garber AJ, Moghissi ES, Bransome ED Jr et al (2004) American College of Endocrinology position statement on inpatient diabetes and metabolic control. Endocr Pract 10(Suppl 2):4–9PubMed Garber AJ, Moghissi ES, Bransome ED Jr et al (2004) American College of Endocrinology position statement on inpatient diabetes and metabolic control. Endocr Pract 10(Suppl 2):4–9PubMed
27.
go back to reference Kadowaki T, Yamauchi T, Kubota N et al (2006) Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. J Clin Invest 116:1784–1792CrossRefPubMed Kadowaki T, Yamauchi T, Kubota N et al (2006) Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. J Clin Invest 116:1784–1792CrossRefPubMed
Metadata
Title
Hyperglycaemia in critical illness is a risk factor for later development of type II diabetes mellitus
Authors
Ivan Gornik
Ana Vujaklija
Edita Lukić
Goran Madžarac
Vladimir Gašparović
Publication date
01-12-2010
Publisher
Springer Milan
Published in
Acta Diabetologica / Issue Special Issue 1/2010
Print ISSN: 0940-5429
Electronic ISSN: 1432-5233
DOI
https://doi.org/10.1007/s00592-009-0115-6

Other articles of this Special Issue 1/2010

Acta Diabetologica 1/2010 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.